Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Uloric-Related Acute Kidney Injury And Acute Renal Failure Pointed Out In Safety Study

January 22, 2020 By Law Offices of Thomas J. Lamb, P.A.

According to a recent medical journal article, acute renal failure (ARF), or kidney failure, is reported as an adverse drug reaction 5.7 times more frequently with Uloric (febuxostat) than with other urate-lowering therapy (ULT) gout drugs, and 3.3 times more often with allopurinol. This is some important new Uloric drug safety information from our … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, acute renal failure, Kidney Failure, Renal Failure, Uloric

SGLT2 Inhibitors May Have an Increased Risk of Acute Renal Failure

October 31, 2017 By Law Offices of Thomas J. Lamb, P.A.

SGLT2 Inhibitors: A New Side Effect In previous articles, I have discussed SGLT2 inhibitor diabetes drugs such as Invokana, Farxiga, and Jardiance and the adverse events associated with them.  Such side effects include diabetic ketoacidosis (DKA) and lower-limb amputations. A recent study identified a new possible side effect of these drugs … [Read more...]

Filed Under: Unsafe Drugs Tagged With: acute renal failure, ARF, diabetes drugs, diabetes drugs renal failure, diabetes drugs side effects, FAERS, Farxiga, FDA Adverse Event Report System Database, Glyxambi, Invokamet, invokamet xr, Invokana, Jardiance, Qtern, sglt2 inhibitors, Sodium-Glucose-Cotransporter-2 Inhibitors, Synjardy, Synjardy XR, type 2 diabetes drugs, xigduo xr

New Federal Court Multidistrict Litigation (MDL) For Farxiga Lawsuits

March 13, 2017 By Law Offices of Thomas J. Lamb, P.A.

There have been drug injury lawsuits filed involving Farxiga (dapagliflozin) and Xigduo XR (dapagliflozin and metformin extended-release), which are relatively new diabetes medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors class of drugs. Those lawsuits recently gave rise to a request for the consolidation of all Farxiga and … [Read more...]

Filed Under: Unsafe Drugs Tagged With: acute renal failure, diabetes drugs, Diabetic Ketoacidosis (DKA), Farxiga, Xigduo

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.